Literature DB >> 18584212

Detection of large deletion mutations in the COL4A5 gene of female Alport syndrome patients.

Kandai Nozu1, Rafal Przybyslaw Krol, Yasufumi Ohtsuka, Koichi Nakanishi, Norishige Yoshikawa, Yoshimi Nozu, Hiroshi Kaito, Kyoko Kanda, Yuya Hashimura, Yuhei Hamasaki, Kazumoto Iijima, Masafumi Matsuo.   

Abstract

Alport syndrome is the most common form of hereditary nephritis, and the majority of cases are caused by mutations in the COL4A5 gene. However, direct sequencing by polymerase chain reaction (PCR), from genomic DNA, or reverse transcriptase-polymerase chain reaction (RT-PCR), from mRNA, or polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) has reportedly resulted in detection rates of 31% to 84%, but of only 20% to 71% when restricted to female patients. This report concerns two female patients with X-linked Alport syndrome. Although mutational analysis of the COL4A5 gene was conducted with direct sequencing using genomic DNA and mRNA extracted from leukocytes, the results were negative for detection of mutations. Semi-quantitative PCR using genomic DNA was therefore conducted to detect large heterozygous deletions. The results were that the first patient showed complete loss of the COL4A5 gene and the second patient showed deletion from exons 37 to 51. Our patients possessed large heterozygous deletions in the COL4A5 gene that could not be detected with the standard direct sequencing method and were identified with semi-quantitative PCR. Previously reported mutation detection rates for female patients have been lower than overall rates. Our findings indicate that this difference may, in part, be due to failure to detect this type of mutation with conventional analytical methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584212     DOI: 10.1007/s00467-008-0878-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport's syndrome by RT-PCR and direct sequencing.

Authors:  Y Inoue; H Nishio; T Shirakawa; K Nakanishi; H Nakamura; K Sumino; K Nishiyama; K Iijima; N Yoshikawa
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

2.  A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome.

Authors:  Kathy King; Frances A Flinter; Peter M Green
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

3.  Mutational analysis of COL4A5 gene in Korean Alport syndrome.

Authors:  H I Cheong; H W Park; I S Ha; Y Choi
Journal:  Pediatr Nephrol       Date:  2000-02       Impact factor: 3.714

4.  Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.

Authors:  J M Hertz; I Juncker; U Persson; G Matthijs; J Schmidtke; M B Petersen; M Kjeldsen; N Gregersen
Journal:  Hum Mutat       Date:  2001-08       Impact factor: 4.878

Review 5.  Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.

Authors:  C E Kashtan
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

6.  X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

Authors:  Jean Philippe Jais; Bertrand Knebelmann; Iannis Giatras; Mario DE Marchi; Gianfranco Rizzoni; Alessandra Renieri; Manfred Weber; Oliver Gross; Kai-Olaf Netzer; Frances Flinter; Yves Pirson; Christine Verellen; Jörgen Wieslander; Ulf Persson; Karl Tryggvason; Paula Martin; Jens Michael Hertz; Cornelis Schröder; Marek Sanak; Sarka Krejcova; Maria Fernanda Carvalho; Juan Saus; Corinne Antignac; Hubert Smeets; Marie Claire Gubler
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

7.  High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.

Authors:  P Martin; N Heiskari; J Zhou; A Leinonen; T Tumelius; J M Hertz; D Barker; M Gregory; C Atkin; U Styrkarsdottir; H Neumann; J Springate; T Shows; E Pettersson; K Tryggvason
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

8.  Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.

Authors:  M Slajpah; B Gorinsek; G Berginc; A Vizjak; D Ferluga; A Hvala; A Meglic; I Jaksa; P Furlan; A Gregoric; S Kaplan-Pavlovcic; M Ravnik-Glavac; D Glavac
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

9.  Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome.

Authors:  Xiaoxia Pan; Jingyin Yan; Hong Ren; Wen Zhang; Hao Shi; Haijin Yu; Chaohui Wang; Cuilan Hao; Xiaonong Chen; Nan Chen
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

10.  X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

Authors:  A Renieri; M Bruttini; L Galli; P Zanelli; T Neri; S Rossetti; A Turco; N Heiskari; J Zhou; R Gusmano; L Massella; G Banfi; F Scolari; A Sessa; G Rizzoni; K Tryggvason; P F Pignatti; M Savi; A Ballabio; M De Marchi
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

View more
  3 in total

1.  Detection by multiplex ligation-dependent probe amplification of large deletion mutations in the COL4A5 gene in female patients with Alport syndrome.

Authors:  Kandai Nozu; Rafal Przybyslaw Krol; Koichi Nakanishi; Norishige Yoshikawa; Yoshimi Nozu; Yasufumi Ohtsuka; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-01-24       Impact factor: 3.714

2.  Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.

Authors:  Kandai Nozu; Shogo Minamikawa; Shiro Yamada; Masafumi Oka; Motoko Yanagita; Naoya Morisada; Shuichiro Fujinaga; China Nagano; Yoshimitsu Gotoh; Eihiko Takahashi; Takahiro Morishita; Tomohiko Yamamura; Takeshi Ninchoji; Hiroshi Kaito; Ichiro Morioka; Koichi Nakanishi; Igor Vorechovsky; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2017-03-09       Impact factor: 3.172

3.  Natural history of genetically proven autosomal recessive Alport syndrome.

Authors:  Masafumi Oka; Kandai Nozu; Hiroshi Kaito; Xue Jun Fu; Koichi Nakanishi; Yuya Hashimura; Naoya Morisada; Kunimasa Yan; Masafumi Matsuo; Norishige Yoshikawa; Igor Vorechovsky; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.